10-K Filing

STREAMEX CORP. CIK: 1530766 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001185185-21-000325`
Period End Date	20201231
Filing Date	20210315
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	biosig20201231_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 32 Cash Flow Statement 70 Stockholders Equity 47

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$12.11M	USD	Point-in-time
Cash	`Cash`	$28.27M	USD	Point-in-time
Inventory	`InventoryNet`	$768.32K	USD	Point-in-time
Inventory	`InventoryNet`	$578.00K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$141.00K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$301.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$180.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$288.56K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$306.48K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$714.34K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$418.84K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$365.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$346.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$317.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$40.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$27.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$5.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$102.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$102.00K	USD	Point-in-time
Total assets	`Assets`	$14.22M	USD	Point-in-time
Total assets	`Assets`	$30.39M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Accounts payable and accrued expenses, including $317 and $40 to related parties as of December 31, 2020 and 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.49M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable and accrued expenses, including $317 and $40 to related parties as of December 31, 2020 and 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.72M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$73.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$129.00K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$412.29K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$312.69K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.32M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.76M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.03M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$720.00	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$311.13K	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$2.34M	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$5.11M	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$215.00K	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 30,764,792 and 23,323,087 issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$23.00K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 30,764,792 and 23,323,087 issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$31.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$115.91M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$181.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-157.00M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$11.15M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$24.37M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$514.83K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$802.27K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$30.39M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$14.22M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$9.74M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$18.14M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$40.95M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$24.81M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$54.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$94.00K	USD	Annual
Total operating expenses	`OperatingExpenses`	$34.60M	USD	Annual
Total operating expenses	`OperatingExpenses`	$59.18M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-34.60M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-59.18M	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$133.00K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$45.00K	USD	Annual
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	$-1.00K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-59.14M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-34.47M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`ProfitLoss`	$-59.14M	USD	Annual
Net loss	`ProfitLoss`	$-34.47M	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-415.85K	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.92M	USD	Annual
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-34.05M	USD	Annual
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-52.22M	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$14.00K	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$25.00K	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-34.08M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-52.23M	USD	Annual
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.87	USD	Annual
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.65	USD	Annual
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	27.91M	shares	Annual
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.69M	shares	Annual

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-59.14M	USD	Annual
Net loss	`ProfitLoss`	$-34.47M	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$54.00K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$94.00K	USD	Annual
Amortization of right of use assets	`AmortizationOfLeasedAsset`	$346.00K	USD	Annual
Amortization of right of use assets	`AmortizationOfLeasedAsset`	$456.00K	USD	Annual
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$15.18M	USD	Annual
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$25.16M	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	$666.00K	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	Annual
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.17M	USD	Annual
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Fair value of warrants to acquire research and development	`WarrantsFairValueOfWarrantsGranted`	$3.16M	USD	Annual
Fair value of warrants to acquire research and development	`WarrantsFairValueOfWarrantsGranted`	-	USD	Annual
Fair value of subsidiary stock issued to acquire research and development	`ShareBasedCompensation`	-	USD	Annual
Fair value of subsidiary stock issued to acquire research and development	`ShareBasedCompensation`	$1.30M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-578.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-287.00K	USD	Annual
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$-100.00K	USD	Annual
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$18.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$119.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$90.00K	USD	Annual
Payment of long term deposit	`IncreaseDecreaseInDeposits`	-	USD	Annual
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$-48.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$538.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.23M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-458.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-340.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.60M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.48M	USD	Annual
Proceeds from disposal of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from disposal of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.00K	USD	Annual
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$111.00K	USD	Annual
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$87.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$177.00K	USD	Annual
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-87.00K	USD	Annual
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-285.00K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$16.16M	USD	Point-in-time
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.21M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.01M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.05M	USD	Point-in-time
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	-	USD	Annual
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	$2.23M	USD	Annual
Proceeds from sale of subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromMinorityShareholders`	$5.01M	USD	Annual
Proceeds from sale of subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromMinorityShareholders`	$10.59M	USD	Annual
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$2.72M	USD	Annual
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$938.00K	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.09M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.47M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.85M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$23.43M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.66M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$16.16M	USD	Annual
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$28.27M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$28.27M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$25.00K	USD	Annual
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$14.00K	USD	Annual
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$422.00K	USD	Annual
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	-	USD	Annual
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$588.00K	USD	Annual
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$2.00K	USD	Annual

Stockholders Equity 47 line items

Line Item	Tag	Value	Unit	Period
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$10.00	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$3.75	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$6.16	USD	Point-in-time
Options, per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$5.44	USD	Annual
Options, per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$5.08	USD	Annual
Preferred Stock, per share	`PreferredStockRedemptionPricePerShare`	$50.00	USD	Point-in-time
Sale of common stock under At-the-market offering, transaction expenses (in Dollars)	`PaymentsOfStockIssuanceCosts`	$93.42K	USD	Point-in-time
Sale of common stock under At-the-market offering, transaction expenses (in Dollars)	`PaymentsOfStockIssuanceCosts`	$222.40K	USD	1 Quarter
Sale of common stock under At-the-market offering, transaction expenses (in Dollars)	`PaymentsOfStockIssuanceCosts`	$100.00	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$4.40M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$9.68M	USD	Annual
Fair value of subsidiary shares issued to acquire research and development	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$1.30M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$10.59M	USD	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$25.21M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.23M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$10.01M	USD	Annual
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	424,357.00	shares	1 Quarter
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.07M	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.50M	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	231,335.00	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.19M	shares	Point-in-time
Sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$5.01M	USD	Annual
Sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$10.59M	USD	Annual
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrants`	$7.47M	USD	Annual
Common stock issued upon exercise of warrants (in Shares)	`StockholdersEquityOtherShares`	83,055.00	shares	1 Quarter
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$938.00K	USD	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.20M	shares	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	550,077.00	shares	Annual
Fair value of warrants issued to acquire research and development	`StockIssuedDuringPeriodValueOther`	$3.16M	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	$666.00K	USD	Annual
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.50M	USD	Annual
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.77M	USD	Annual
Preferred Stock dividend	`DividendsPreferredStock`	$14.00K	USD	Annual
Preferred Stock dividend	`DividendsPreferredStock`	$25.00K	USD	Annual
Net loss	`ProfitLoss`	$-59.14M	USD	Annual
Net loss	`ProfitLoss`	$-34.47M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.